0713 GMT - China's recent AI breakthrough could boost the efficiency of its healthcare sector and enable other potential novel services, Jefferies analyst Cui Cui says in an email. Chinese health-tech stocks are broadly higher in Hong Kong, with Alibaba Health Information up 25% and Ping An Health and Technology gaining 14%. Chinese contract drug makers WuXi AppTec and WuXi Biologics are 8.4% and 11% higher, respectively. Although these stocks aren't direct beneficiaries of the AI concept, they are likely rallying on their significant underweight positions and the fundamental shift in market sentiment after the Biosecure Act wasn't passed under the Biden administration, Cui adds. Her top industry picks in 2025 are WuXi Bio due to its better new order growth momentum and JD Health because of its AI development potential. (sherry.qin@wsj.com)
(END) Dow Jones Newswires
February 14, 2025 02:13 ET (07:13 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。